Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8598160
APP PUB NO 20110071139A1
SERIAL NO

12867374

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention relates to novel compounds of the Formula (I), any of the formulas I1-I26 1a1-3-1j1-3 or pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful for the therapeutic treatment of diseases associated with the modulation or inhibition of 11β-HSD1 in mammals. The invention further relates to pharmaceutical compositions of the novel compounds and methods for their use in the reduction or control of the production of cortisol in a cell or the inhibition of the conversion of cortisone to cortisol in a cell.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VITAE PHARMACEUTICALS INC502 WEST OFFICE CENTER DRIVE FORT WASHINGTON PA 19034

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Claremon, David A Maple Glen, US 167 2136
Simpson, Robert D Wilmington, US 34 299
Singh, Suresh B Kendall Park, US 95 1396
Tice, Colin M Ambler, US 98 1489
Ye, Yuanjie Ambler, US 25 720
Zhuang, Linghang Chalfont, US 88 1113

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 3, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00